Please activate JavaScript!
Please install Adobe Flash Player, click here for download

today IDS Cologne Show Preview

n Myofunctional Research Co. (MRC) has been developing innovative intra- oral appliances to treat the causes of malocclusion and TMJ disorder for all ages of growing children since 1989. At IDS 2011, the company will dem- onstrate practical and cost-effective means of delivering advanced my- ofunctional correction for every child. However, MRC is developing more than just orthodontic appliances. In 2009, their MRC Clinics was launched which provided the industry with a totally new way of treating myofunc- tionalhabitsingrowingchildrenforbet- terdentalalignmentandfacialdevelop- ment. It also offered a profitable and morecost-effectivesolutiontotheprob- lemsandlimitationsoftraditionaltreat- ment methods orthodontists and their tendency to failure in the long-term. In addition, the com- pany has a strong focus onadvancingknowledge through developing edu- cational materials on the importance of correcting myofunctional habits in children as early as pos- sible.Themaingoalisnot just straightening teeth without braces but to make a lifelong positive impact on their develop- ment and health, the company says. They say that this dedication to deliv- ering quality educational materials is a crucial part of their role as an active educational company. 7 MYOFUNCTIONAL RESEARCH, AUSTRALIA www.myoresearch.com Hall 11.3 Booth E030 industry20 Show Preview IDS Cologne 2011 MRC provides education for a healthier future AD 5 Founder and CEO Dr Chris Farrell (middle, DTI/Photo courtesy of Myofunctional Research, Australia) n At this year’s IDS, Ivoclar Vivadent will present innovations from the competence areas all-ceramics, direct restoratives and implant prosthetics. The company has taken the IPS e.max system to the next level by introdu- cing the IPS e.max CAD-on technique. With this technique, users can fab- ricate high-strength and highly es- theticbridgerestorationsconsistingof IPS e.max CAD (LS2) and IPS e.max ZirCAD (ZrO2) material. Visitors can also look forward to the introduction of an innovative in- got which opens up new opportuni- ties in the press technology. Ivoclar Vivadent’s press furnace technology hasalsobeenimproved.Anotherhigh- light in the field of all-ceramics will be a cleaning paste that has been espe- ciallydesignedtocreateoptimumcon- ditions for the adhesive cementation of restorations and thus to provide increased reliability. Furthermore, a multimediatooloncementationisalso bound to be launched. Intheareaofhighlyaestheticcom- posite materials, such as IPS Empress Direct, the company will present new materials which can be used for the characterization of restorations and the masking of discoloured teeth. Visitors will have the chance to learn about the advantages of the light-curing, universal nano-hybrid composite Tetric EvoCeram on site. This product has undergone an exten- sive redesign. Tetric EvoCeram will furthermore be supplied in additional shades. In the field of implant prosthetics, high-quality products for removable and fixed denture prosthetics will be introduced including products for im- plant-borne complete and partial den- tures, fabricated for instance with the nano-hybrid composite SR Phonares NHCteeth,andnewalloys.Inaddition, the company is extending its range of cementationoptionstoincludeamate- rial for the cementation of permanent or temporary restorations on implant abutments. 7 IVOCLAR VIVADENT, LIECHTENSTEIN www.ivoclarvivadent.com Hall 11.3 Booth A015 A series of innovative products